Breast cancer with overexpression of human epidermal growth factor receptor 2 (HER2) accounted for 20–30% of all breast cancers and had poorer prognosis (Vu and Claret, 2012; Robidoux et al., 2013). The gene discussed is ERBB2; the disease is breast carcinoma.